A highly integrated precision nanomedicine strategy to target esophageal squamous cell cancer molecularly and

Xin-Shuai Wang1, Xue-Zhen Ding1, Xiao-Cen Li2

  • 1Henan Key Laboratory of Cancer Epigenetics; Cancer hospital, The First Affiliated Hospital, College of Clinical Medicine, Medical College of Henan University of Science and Technology, Luoyang, China.

Insights

This study introduces a novel nanomedicine approach for esophageal squamous cell carcinoma (ESCC) treatment. Combining targeted drug delivery of docetaxel and a PI3K inhibitor significantly improved efficacy and reduced side effects in ESCC.

Area of Science:

  • Oncology
  • Nanomedicine
  • Molecular Biology

Background:

  • Esophageal squamous cell carcinoma (ESCC) has a poor prognosis, necessitating improved therapeutic strategies.
  • PI3K pathway is frequently overexpressed in ESCC and correlates with reduced patient survival.
  • Current ESCC treatments often face challenges with efficacy and significant toxicity.

Purpose of the Study:

  • To develop and evaluate a precision nanomedicine strategy for targeting ESCC.
  • To investigate the synergistic anti-tumor effects of combining docetaxel (DTX) and a PI3K inhibitor (AZD8186) delivered via a nanomedicine platform.
  • To assess the impact of this combination therapy on tumor response and systemic toxicity.

Main Methods:

  • Identification of PI3K overexpression in ESCC patient samples.
  • Development of a versatile tumor-targeted drug delivery platform (DCM) capable of co-delivering DTX and AZD8186.
  • In vitro evaluation of the combined nanomedicine therapy's efficacy, synergy, and impact on apoptosis-related proteins (Bax).
  • Assessment of hematotoxicity associated with the combination therapy compared to monotherapy.

Main Results:

  • The nanomedicine platform (DCM) successfully co-delivered DTX and AZD8186.
  • Combination therapy demonstrated highly efficacious and synergistic anti-tumor activity against ESCC.
  • Treatment with the combined DTX-DCM and AZD8186-DCM significantly upregulated the pro-apoptotic protein Bax.
  • The combination therapy resulted in decreased hematotoxicity compared to monotherapy.

Conclusions:

  • A highly integrated precision nanomedicine strategy targeting molecular (PI3K) and physical aspects of ESCC was developed.
  • This approach offers a promising avenue for significantly improving ESCC treatment efficacy through synergistic combination therapy.
  • The study highlights the potential of precision nanomedicine in advancing cancer treatment by integrating patient-specific targets with advanced drug delivery systems.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.9K
Uncertainty in Measurement: Accuracy and Precision03:37

Uncertainty in Measurement: Accuracy and Precision

Scientists typically make repeated measurements of a quantity to ensure the quality of their findings and to evaluate both the precision and the accuracy of their results. Measurements are said to be precise if they yield very similar results when repeated in the same manner. A measurement is considered accurate if it yields a result that is very close to the true or the accepted value. Precise values agree with each other; accurate values agree with a true value. 
102.7K
Molecular Models02:00

Molecular Models

Physical models representing molecular architectures of chemical compounds play essential roles in understanding chemistry. The use of molecular models makes it easier to visualize the structures and shapes of atoms and molecules.
43.8K
Esophageal Varices-I: Introduction01:24

Esophageal Varices-I: Introduction

Esophageal varices are dilated, tortuous veins which are found mainly in the submucosa of the lower esophagus but which may also appear higher up or extend into the stomach. They develop due to increased pressure in the portal venous system, often as a result of liver cirrhosis. This condition scars and damages the liver, impeding normal blood flow through the portal vein. To compensate, blood seeks alternative pathways, forming fragile new vessels (varices) in the esophagus and stomach. These...
1.5K
Physical and Chemical Properties of Matter02:57

Physical and Chemical Properties of Matter

The characteristics that enable us to distinguish one substance from another are called properties.
166.7K
Esophageal Perforation-I: Introduction01:22

Esophageal Perforation-I: Introduction

Esophageal perforation is a severe medical condition characterized by a breach in the integrity of the esophageal wall. This breach can occur due to various factors such as trauma, medical procedures, or underlying diseases. When the esophageal wall is compromised, it allows food, fluids, and digestive juices into the chest cavity or adjacent structures, leading to potential complications and health risks.
The location of esophageal perforation can vary, occurring anywhere along the esophagus....
619